The University of Kentucky’s College of Public Health welcomes GYeon Oh, PhD, is a Postdoctoral Scholar in the Department of Epidemiology and Environmental Health at the College of Public Health.
External Link
“How safe is “safer than opioids”? Investigating risks and benefits of gabapentin use among older adults.”
GYeon Oh, BPharm, PhD, is a Postdoctoral Scholar at the Department of Epidemiology and Environmental Health, University of Kentucky. She completed her PhD in Epidemiology and Biostatistics at the College of Public Health, University of Kentucky, specializing in pharmacoepidemiology. After graduation, she continued her research as a Postdoctoral Scholar at the UK College of Pharmacy and a T32-supported Postdoctoral Fellow at the Sanders-Brown Center on Aging.
Dr. Oh’s area of research focuses on examining the association between pain treatment/ substance drug use and health outcomes in vulnerable populations. During her doctoral program, her dissertation focused on opioid use in vulnerable populations, including older adults and patients with HIV. As a graduate research assistant, working at the Kentucky Injury Prevention Research Center, she started to investigate the utilization of gabapentin after its reclassification in Kentucky as a Schedule V drug. Throughout this project, she realized that the prevalence of gabapentin use was high in older adults, although the benefits and risks of gabapentin in this population have not been well studied. To further explore this, Dr. Oh’s current research focuses on characterizing gabapentin use in older adults and examining the risks and benefits of gabapentin use on health-related outcomes (e.g., neurocognitive change, falls, fractures, and hospitalizations).
